Jun Li| AI-powered biomaterials | Best Researcher Award

Prof Jun Li | AI-powered biomaterials | Best Researcher Award

COA Outstanding Young Orthopedic Physician award, West China Hospital, Sichuan University, China

Jun Li’s work stands out in the field of Orthopedics and biomedical research due to his innovative contributions to bone tissue regeneration, orthopedic oncology, and regenerative medicine. His extensive academic qualifications, publication record, patent contributions, and clinical trials demonstrate his ability to bridge the gap between theoretical research and clinical applications. Furthermore, his leadership roles and active involvement in professional organizations reflect his commitment to advancing the field and mentoring the next generation of researchers.

Publication Profile
scopus

Education :

  • Postdoctoral Fellow
    2019/07 – 2022/12
    West China Hospital of Stomatology, Sichuan University, China

  • Joint Ph.D. Program
    2017/08 – 2019/08
    Harvard Medical School, USA

  • Ph.D. in Clinical Medicine
    2016/09 – 2019/06
    West China College of Clinical Medicine, Sichuan University, China

  • Master’s Degree in Clinical Medicine
    2013/09 – 2016/06
    Wuhan University School of Clinical Medicine, China

EXPERIENCE:

  • Associate Professor and Associate Researcher
    Department of Orthopedics, West China Hospital, Sichuan University, China
    Current Position

  • Principal Investigator
    Chengdu Advanced Medical Center, China
    Current Position

  • Postdoctoral Fellow
    Harvard Medical School, USA
    2017-2019

Skills:

  • Orthopedic Surgery & Oncology
    Expertise in clinical and experimental orthopedic surgery, specifically in bone and joint diseases, bone cancer, and trauma recovery.

  • 3D Bioprinting & Biomaterials
    Focus on developing hybrid scaffolds for bone tissue regeneration and bioprinted tumor models.

  • Stem Cell Therapy
    Expertise in utilizing bone marrow mesenchymal stem cells for promoting bone repair and spinal cord injury recovery.

  • Clinical Trials Management
    Experience as a principal investigator in Phase II and III clinical trials, particularly focusing on bone regeneration and orthopedic oncology.

Awards:

  • COA Outstanding Young Orthopedic Physician Paper Award
  • Second Huaxi Orthopedic Young Development Fund ESI High Citation Paper Award
  • Tomorrow Star Award
  • Selected as Young Talent in the Tianfu Emei Plan
  • High-level Overseas Talent in Sichuan Province

Research Focus:

Jun Li’s research lies at the intersection of orthopedics, biomaterials, and regenerative medicine. His work primarily focuses on the development and application of advanced biomaterials, including 3D bioprinting, for bone tissue regeneration, orthopedic oncology, and spinal injuries. His studies explore the role of stem cells in tissue repair and regeneration, particularly in bone defects, spinal cord injuries, and cancer-related orthopedic conditions. Jun Li has made significant contributions to developing innovative scaffolds and treatment modalities that combine stem cell therapy and advanced biomaterials.

 

Publication :

      • Li J, Parra-Cantu C, Wang Z, Zhang YS. Improving Bioprinted Volumetric Tumor Microenvironments In Vitro. Trends Cancer, 2020, 6(9): 745-756. (IF=19.161, B)

      • Li J, Lai Y, Li M, Chen X, Zhou M, Wang W, et al. Repair of infected bone defect with Clindamycin-Tetrahedral DNA nanostructure Complex-loaded 3D bioprinted hybrid scaffold. Chem Eng J, 2022, 435: 134855. (IF=16.744, B)

      • Wu D, Wang Z, Li J, Song Y, Perez MEM, Wang Z, et al. A 3D‐Bioprinted Multiple Myeloma Model. Adv Healthc Mater, 2021. (IF=11.092, B)

      • Zhou M, Zhang T, Zhang X, Li J, et al. The Effect of Tetrahedral Framework Nucleic Acids on Neurological Recovery via Ameliorating Apoptosis, Regulating the Activation and Polarization of Astrocytes in Ischemic Stroke. ACS Appl Mater Inter., 2022. (IF=10.383)

      • Li J, Wang W, Li M, Song P, Lei H, Gui X, et al. Biomimetic Methacrylated Gelatin Hydrogel Loaded With Bone Marrow Mesenchymal Stem Cells for Bone Tissue Regeneration. Front Bioeng Biotech, 2021, 9: 770049. (IF=6.064, D)

      • Li J, Huang Z, Chen L, Tang X, Fang Y, Liu L. Restoration of bone defects using modified heterogeneous deproteinized bone seeded with bone marrow mesenchymal stem cells. Am J Transl Res, 2017, 9(7): 3200-3211. (IF=3.940, D)

      • Wang W, Li J, Zhang Z, Ma H, Li Q, Yang H, et al. Genome-wide analysis of acute traumatic spinal cord injury-related RNA expression profiles and uncovering of a regulatory axis in spinal fibrotic scars. Cell Prolif, 2021, 54(1): e12951. (IF=8.755, C)Wang W-Z, Li J, Liu L, Zhang Z-D, Li M-X, Li Q, et al. Role of circular RNA expression in the pathological progression after spinal cord injury. Neural Regen Res, 2021, 16(10): 2048-2055. (IF=6.058, D)

      • Wang W, Ma L, Li J, Yang SY, Yi Z, Sun M, et al. Identification and coregulation pattern analysis of long noncoding RNAs following subacute spinal cord injury. J Orthop Res, 2022, 40(3): 661-673. (IF=3.102, D)

      • Li J, Wang W, Li M, Liu L. Repair of segmental bone defect using tissue engineered heterogeneous deproteinized bone doped with lithium. Sci Rep, 2021, 11(1): 4819. (IF=4.996, D)

      • Li B, Li J, Wang S, Liu L. Clinical analysis of peri-operative hidden blood loss of elderly patients with intertrochanteric fractures treated by unreamed proximal femoral nail anti-rotation. Sci Rep, 2018, 8(1): 3225. (IF=4.996, D)

      • Li J, Li B, Zhang Z, Wang S, Liu L. Ilizarov external fixation versus plate internal fixation in the treatment of end-stage ankle arthritis: decision analysis of clinical parameters. Sci Rep, 2017, 7(1): 16155. (IF=4.996, D)

      • Li J, Guo W, Xiong M, Han H, Chen J, Mao D, et al. Effect of SDF-1/CXCR4 axis on the migration of transplanted bone mesenchymal stem cells mobilized by erythropoietin toward lesion sites following spinal cord injury. Int J Mol Med, 2015, 36(5): 1205-1214. (IF=5.314, D)

      • Li J, Guo W, Xiong M, Zhang S, Han H, Chen J, et al. Erythropoietin facilitates the recruitment of bone marrow mesenchymal stem cells to sites of spinal cord injury. Exp Ther Med, 2017, 13(5): 1806-1812. (IF=2.751, E)

      • Li J, Liu L. Comparison of short-segment versus long-segment fixation for the treatment of thoracolumbar burst fracture: A meta-analysis. Int J Cli Expl Med, 2017, 10: 1750-1762.

      • Li J, Wang W, Li M, Li B, Liu L. Evolution and Development of Ilizarov Technique in the Treatment of Infected Long Bone Nonunion with or without Bone Defects. Orthop Surg, 2022. (IF=2.279, C)

      • Li J, Wang W, Yang H, Li B, Liu L. Management of elderly traumatic ankle arthritis with Ilizarov External Fixation. Orthop Surg, 2022. (IF=2.279, C)

CONCLUSION:

Jun Li is highly deserving of the Best Researcher Award due to his outstanding contributions to orthopedic and biomedical research. His leadership in various research projects, published work in high-impact journals, successful clinical trial involvement, and significant patents highlight his status as an influential researcher in his field. Expanding his collaborative networks, public outreach, and mentorship efforts will only further enhance his contributions and ensure his continued success as a leader in medical science.